Skip to content

Nurse-based management screening in patients with gestational diabetes

Can a nurse-based management screening ensure adequate outcomes in patients with gestational diabetes? A comparison of two organizational models

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15443219
Enrollment
450
Registered
2017-09-21
Start date
2013-10-15
Completion date
Unknown
Last updated
2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes Nutritional, Metabolic, Endocrine Gestational diabetes

Interventions

Participant are not randomised since the control group is the group of patients before the protocol. The duration of intervention is the pregnancy period and starts at the diagnosis moment and finishe

Sponsors

Aulss 2 Marca Trevigiana distretto di Treviso
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Not have type 1 or type 2 diabetes before becoming pregnant 2. Have balanced food habits (50-60% carbohydrates; 10-15% protein; 20-25% fats) based on a Mediterranean-style diet 3. Have a pre-pregnancy BMI of between 18 and 35 kg/m2 4. Not having an eating disorder or by any type of prior or current psychiatric illness 5. Not having a heart, kidney or liver disease, thrombophilic diathesis or any other already diagnosed chronic disease (e.g. hereditary dyslipdemia, hypertension resistant to treatment with drugs, gout, etc.) before becoming pregnant 6. Not having pre-eclampsia during a previous pregnancy 7. Not having a history of recurrent fetal loss 8. Not having cancer (current or previous) 9. Not expecting twins 10. Aged between 18-45

Exclusion criteria

Exclusion criteria: 1. Morphological ultrasound scan showed evidence of a fetal malformation or soft markers for chromosomal abnormality 2. Invasive diagnosis (chorionic villus sampling or amniocentesis) showed fetal chromosomal abnormality

Design outcomes

Primary

MeasureTime frame
Hypoglycemia is measured using their personal glucose monitor when they feel symptoms, as instructed.

Secondary

MeasureTime frame
Number of medical visits is measured using patient number of recorded accesses in the Hospital booking system.

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026